These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 2115297

  • 21. Single and multiple administration of a new triphasic oral contraceptive to women: pharmacokinetics of ethinyl estradiol and free and total testosterone levels in serum.
    Kuhnz W, Sostarek D, Gansau C, Louton T, Mahler M.
    Am J Obstet Gynecol; 1991 Sep; 165(3):596-602. PubMed ID: 1892184
    [Abstract] [Full Text] [Related]

  • 22. Effect of contraceptive steroids on serum levels of sex hormone binding globulin and caeruloplasmin.
    Limpongsanurak S, Jenkins N, Fotherby K.
    Curr Med Res Opin; 1981 Sep; 7(3):185-91. PubMed ID: 7194172
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles.
    Kuhnz W, Staks T, Jütting G.
    Contraception; 1993 Dec; 48(6):557-75. PubMed ID: 8131397
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of levonorgestrel in Indian women belonging to low socio-economic group.
    Nair KM, Sivakumar B, Prema K, Rao BS.
    Contraception; 1979 Sep; 20(3):303-17. PubMed ID: 509957
    [Abstract] [Full Text] [Related]

  • 25. Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications.
    Goldzieher JW.
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):318-22. PubMed ID: 2196804
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics of oral contraceptive steroids following the administration of the antimalarial drugs primaquine and chloroquine.
    Back DJ, Breckenridge AM, Grimmer SF, Orme ML, Purba HS.
    Contraception; 1984 Sep; 30(3):289-95. PubMed ID: 6439467
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol.
    Archer DF, Timmer CJ, Lammers P.
    Fertil Steril; 1994 Apr; 61(4):645-51. PubMed ID: 8150105
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis.
    Stead RJ, Grimmer SF, Rogers SM, Back DJ, Orme ML, Hodson ME, Batten JC.
    Thorax; 1987 Jan; 42(1):59-64. PubMed ID: 3112991
    [Abstract] [Full Text] [Related]

  • 29. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
    Price TM, Dupuis RE, Carr BR, Stanczyk FZ, Lobo RA, Droegemueller W.
    Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
    [Abstract] [Full Text] [Related]

  • 30. Morphometric study of the human endometrium following continuous exposure to levonorgestrel released from vaginal rings during 90 days.
    Johannisson E, Brosens I, Cornillie F, Elder M, White J, Sheppard B, Hourihan H, d'Arcangues C, Belsey EM.
    Contraception; 1991 Apr; 43(4):361-74. PubMed ID: 1906792
    [Abstract] [Full Text] [Related]

  • 31. The relative bioavailability of levonorgestrel and ethinylestradiol when administered in tablet and capsule form.
    Back DJ, Killick SR, Stevenson PJ, Shenoy N, Elstein M, Cohen M.
    Contraception; 1987 Sep; 36(3):321-6. PubMed ID: 3119288
    [Abstract] [Full Text] [Related]

  • 32. Influence of high doses of vitamin C on the bioavailability and the serum protein binding of levonorgestrel in women using a combination oral contraceptive.
    Kuhnz W, Louton T, Hümpel M, Back DJ, Zamah NM.
    Contraception; 1995 Feb; 51(2):111-6. PubMed ID: 7750288
    [Abstract] [Full Text] [Related]

  • 33. Changes in unbound sex steroids and sex hormone binding globulin--binding capacity during oral and vaginal progestogen administration.
    Granger LR, Roy S, Mishell DR.
    Am J Obstet Gynecol; 1982 Nov 01; 144(5):578-84. PubMed ID: 6890312
    [Abstract] [Full Text] [Related]

  • 34. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA, Brenner PF, Kletzky OA, Mishell DR.
    Am J Obstet Gynecol; 1978 Apr 01; 130(7):817-21. PubMed ID: 345817
    [Abstract] [Full Text] [Related]

  • 35. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Apr 01; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 36. Some estrogenic effects of two oral contraceptives consisting of norgestrel and two different doses of ethynylestradiol.
    Miller JF, Fotherby K, Bye PG, Elstein M.
    Contraception; 1979 Jul 01; 20(1):5-10. PubMed ID: 573191
    [Abstract] [Full Text] [Related]

  • 37. Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant implants.
    Alvarez F, Brache V, Tejada AS, Cochon L, Faundes A.
    Contraception; 1998 Oct 01; 58(4):211-4. PubMed ID: 9866001
    [Abstract] [Full Text] [Related]

  • 38. [Pharmacokinetic and pharmacodynamic studies on vaginally administered levonorgestrel].
    He CH.
    Shengzhi Yu Biyun; 1991 Nov 01; 11(4):12-8. PubMed ID: 12284919
    [Abstract] [Full Text] [Related]

  • 39. Hormonal and nonhormonal factors affecting sex hormone-binding globulin levels in blood.
    Thijssen JH.
    Ann N Y Acad Sci; 1988 Nov 01; 538():280-6. PubMed ID: 3056190
    [Abstract] [Full Text] [Related]

  • 40. The interaction between sex hormone binding globulin and levonorgestrel released from vaginal rings in women.
    Cekan SZ, Jia M, Landgren BM, Diczfalusy E.
    Contraception; 1985 Apr 01; 31(4):431-9. PubMed ID: 3924477
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.